Suchergebnisse - "Cao, Lei"

PubPharm (29)

1

Is NAD(P)H quinone oxidoreductase 1 a tumor promoter or suppressor in gastric cancer?

enthalten in: Frontiers in oncology | 2023

von Cao, L. | Chen, Y. | Xu, S. | +1

2

Comprehensive genomic profiling reveals prognostic signatures and insights into the molecular landscape of colorectal cancer

enthalten in: Frontiers in oncology | 2023

von Yang, J. | Zhao, S. | Su, J. | +12

3

Giant functional parathyroid carcinoma : a case report and literature review

enthalten in: Frontiers in oncology | 2023

von Wu, J. | Sun, Y. | Zhang, Q. | +6

4

Clinical significance of CD155 expression and correlation with cellular components of tumor microenvironment in gastric adenocarcinoma

enthalten in: Frontiers in immunology | 2023

von Liu, X. | Xu, C. | Guo, T. | +7

5

A simplified prognostic score for T-cell large granular lymphocyte leukaemia

enthalten in: Annals of medicine | 2023

von Liu, H. | Guo, J. | Cao, L. | +7

6

Correlations between the expression of molecules in the TGF-β signaling pathway and clinical factors in adamantinomatous craniopharyngiomas

enthalten in: Frontiers in endocrinology | 2023

von Jin, L. | Cai, K. | Wu, W. | +12

7

Treatment and 1-Year Prognosis of Ischemic Stroke in China in 2018 : A Hospital-Based Study From Bigdata Observatory Platform for Stroke of China

enthalten in: Stroke | 2022

von Tu, W. | Yan, F. | Chao, B. | +2

8

Metformin use is associated with low risk of case fatality and disability rates in first-ever stroke patients with type 2 diabetes

enthalten in: Therapeutic advances in chronic disease | 2022

von Tu, W. | Liu, Z. | Chao, B. | +5

9

B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer

enthalten in: Frontiers in oncology | 2022

von Zhu, Z. | Teng, K. | Zhou, J. | +23

10

Evaluation of the role of soluble B7-H3 in association with membrane B7-H3 expression in gastric adenocarcinoma

enthalten in: Cancer biomarkers : section A of Disease markers | 2022

von Huang, L. | Zhou, Y. | Sun, Q. | +2